VAN-Ferrous Fumarate

Natural health product licensed in Canada

Licence holder: Avricore Health Inc.
NPN or DIN-HM: 80079607
Status: Inactive licence
Licence date: 22 August 2017
Revision date: 6 November 2017
Form: Comprimé
Route of administration: Orale
Application type: Non traditionnelle

If this product were sold in France

Dose déclarée au-delà d'une limite
Fer: up to 97.5 mg a day according to the dosing instructions published by Health Canada (1 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 14 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
À vérifier
Fer: up to 97.5 mg a day according to the dosing instructions published by Health Canada, above the niveau de sécurité from EFSA for adults (40 mg a day). Son dépassement ne permet pas, à lui seul, de caractériser un risque : l'EFSA n'a pas pu fixer de limite supérieure pour ce nutriment. Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
niveau de sécurité. EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.

A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source	Maximum per day, adult
Fer Source : Fumarate de fer (II)	97.5 milligramme	97,500 µg

Non-medicinal ingredients

Dioxyde de silicium colloïdal, Hypromellose, Croscarmellose de sodium, Amidon prégélatinisé, Talc, Stéarate de magnésium, Cellulose microcristalline, Ponceau 4R, Dioxyde de titane, Poly(éthylène glycol), Povidone, Éthyl cellulose

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Adultes	Not specified	1 Comprimé	1 day

Uses authorised in Canada

For the treatment of iron Deficient Anemia.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

Contre-indications
Consult a health care practitioner prior to use if you: - have hereditary hemochromatosis, other conditions of iron overloading (including blood transfusions), peptic ulcer, regional enteritis, ulcerative colitis and/or other gastro-intestinal concerns; - experience symptoms of iron toxicity such as nausea, vomiting, abdominal pain, hematemesis (vomiting of blood) and discontinue usage. - are pregnant or breast-feeding.
Précautions et mises en garde
FOR THERAPEUTIC USE ONLY. DO NOT USE EXCEPT UNDER THE CARE OF A PHYSICIAN.Keep put of reach of children. There is enough drug in this package to seriously harm a child. DO NOT USE IF THE SEAL UNDER CAP IS BROKEN; CHILD RESISTANT CAP.
Effets indésirables connus
May experience constipation, diarrhoea, abdominal cramps and/or vomiting.

Source

Official Health Canada record, licence 80079607

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

List in the official revision dated 6 November 2017 (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).

List recorded in 2017. Photograph the packaging to check whether it has changed. Photograph the packaging